News
HOMENews
News
| No | Title | Writer | Date | Hit |
|---|---|---|---|---|
| 22 | LyseNTech filed IND for phase 1 clinical trial of its endolysin | LyseNTech | 2023-11-23 | 8 |
| 21 | LyseNTech acquired US patent for endolysin LNT103 | LyseNTech | 2023-11-22 | 13 |
| 20 | LyseNTech won the grand prize at the 2023 Gyeonggi Startup Investment Conference & Global Day | LyseNTech | 2023-11-03 | 78 |
| 19 | Heejoon Myung, CEO of LyseNTech, presented at the 2023 Korean Society of Infectious Diseases | LyseNTech | 2023-11-03 | 63 |
| 18 | Poster presentation in World AMR Congress 2023 (Philadelphia, USA) | LyseNTech | 2023-09-21 | 95 |
| 17 | Oral presentation in The 1st International Symposium for Infectious Diseases Research Institutes Cooperation | LyseNTech | 2023-09-21 | 91 |
| 16 | Oral presentation in 26th Congress of the Asian Pacific Society of Respirology | LyseNTech | 2023-09-21 | 95 |
| 15 | Participation in Phage Australia | LyseNTech | 2023-09-21 | 93 |
| 14 | Governmental project awarded | LyseNTech | 2023-09-21 | 87 |
| 13 | Series A funding | LyseNTech | 2023-09-21 | 89 |
